151 related articles for article (PubMed ID: 10720470)
1. Enhanced lipid oxidation by oxidatively modified myoglobin: role of protein-bound heme.
Vuletich JL; Osawa Y; Aviram M
Biochem Biophys Res Commun; 2000 Mar; 269(3):647-51. PubMed ID: 10720470
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron.
Grinshtein N; Bamm VV; Tsemakhovich VA; Shaklai N
Biochemistry; 2003 Jun; 42(23):6977-85. PubMed ID: 12795592
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation.
Miller YI; Felikman Y; Shaklai N
Arch Biochem Biophys; 1996 Feb; 326(2):252-60. PubMed ID: 8611031
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin.
Miller YI; Altamentova SM; Shaklai N
Biochemistry; 1997 Oct; 36(40):12189-98. PubMed ID: 9315856
[TBL] [Abstract][Full Text] [Related]
6. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation.
Miller YI; Smith A; Morgan WT; Shaklai N
Biochemistry; 1996 Oct; 35(40):13112-7. PubMed ID: 8855948
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
Johnston TP; Zhou X
J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
[TBL] [Abstract][Full Text] [Related]
8. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.
Reeder BJ; Wilson MT
Chem Res Toxicol; 2005 Jun; 18(6):1004-11. PubMed ID: 15962935
[TBL] [Abstract][Full Text] [Related]
9. Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification.
Kapiotis S; Hermann M; Exner M; Sturm BN; Scheiber-Mojdehkar B; Goldenberg H; Kopp S; Chiba P; Gmeiner BM
Free Radic Res; 2005 Nov; 39(11):1225-31. PubMed ID: 16298749
[TBL] [Abstract][Full Text] [Related]
10. Molecular engineering of myoglobin: influence of residue 68 on the rate and the enantioselectivity of oxidation reactions catalyzed by H64D/V68X myoglobin.
Yang HJ; Matsui T; Ozaki S; Kato S; Ueno T; Phillips GN; Fukuzumi S; Watanabe Y
Biochemistry; 2003 Sep; 42(34):10174-81. PubMed ID: 12939145
[TBL] [Abstract][Full Text] [Related]
11. Phenylalanine substitution at site B10 (L29F) inhibits metmyoglobin formation and myoglobin-mediated lipid oxidation in washed fish muscle: mechanistic implications.
Richards MP; Cai H; Grunwald EW
J Agric Food Chem; 2009 Sep; 57(17):7997-8002. PubMed ID: 19678685
[TBL] [Abstract][Full Text] [Related]
12. Horse heart myoglobin catalyzes the H2O2-dependent oxidative dehalogenation of chlorophenols to DNA-binding radicals and quinones.
Osborne RL; Coggins MK; Walla M; Dawson JH
Biochemistry; 2007 Aug; 46(34):9823-9. PubMed ID: 17676875
[TBL] [Abstract][Full Text] [Related]
13. Modification of low-density lipoprotein by different radioiodination methods.
Sobal G; Resch U; Sinzinger H
Nucl Med Biol; 2004 Apr; 31(3):381-8. PubMed ID: 15028251
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of heme protein-mediated lipid oxidation using hemoglobin and myoglobin variants in raw and heated washed muscle.
Grunwald EW; Richards MP
J Agric Food Chem; 2006 Oct; 54(21):8271-80. PubMed ID: 17032039
[TBL] [Abstract][Full Text] [Related]
15. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of low-density lipoprotein by hemoglobin-hemichrome.
Bamm VV; Tsemakhovich VA; Shaklai N
Int J Biochem Cell Biol; 2003 Mar; 35(3):349-58. PubMed ID: 12531248
[TBL] [Abstract][Full Text] [Related]
17. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
Sobal G; Resch U; Tatzber F; Sinzinger H
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
[TBL] [Abstract][Full Text] [Related]
18. Chemiluminescence assay for oxidatively modified myoglobin.
Vuletich JL; Osawa Y
Anal Biochem; 1998 Dec; 265(2):375-80. PubMed ID: 9882417
[TBL] [Abstract][Full Text] [Related]
19. Oximes as inhibitors of low density lipoprotein oxidation.
de Lima Portella R; Barcelos RP; de Bem AF; Carratu VS; Bresolin L; da Rocha JB; Soares FA
Life Sci; 2008 Dec; 83(25-26):878-85. PubMed ID: 18992260
[TBL] [Abstract][Full Text] [Related]
20. Role of heme types in heme-copper oxidases: effects of replacing a heme b with a heme o mimic in an engineered heme-copper center in myoglobin.
Wang N; Zhao X; Lu Y
J Am Chem Soc; 2005 Nov; 127(47):16541-7. PubMed ID: 16305243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
